I
Immunocore
TCR bispecific immunotherapies for cancer and infectious diseases
At a glance
- Status
- Listed
- Listing
- IPO 2021
News
Open roles
Immunocore in the Milton ecosystem
The Immunocore office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- ELEli Lilly
- WMWoodford Investment Management
- RIRTW Investments
Series B and later9 investors entered at this stage
- JFJDRF T1D Fund
- RCRock Springs Capital
General Atlantic- WVWuXi Healthcare Ventures
BlackRock- BFBill & Melinda Gates Foundation
- CICCB International
- OFOmega Funds
- UOUniversity of Oxford
Source: Dealroom Talent Intelligence.
Alumni founders
Former Immunocore employees who went on to found companies, sorted by Dealroom signal score.
Julian HirstUnited Kingdom
ADAdaptimmuneEst. 2008
Bent JakobsenUnited KingdomPatents
54 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Immunocore on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


